translate arrow

freightHub2020 BannerSMALL


freightHub2020 BannerSMALL


BRUSSELS/HONG KONG: January 07, 2019. Brussels Airport and Hong Kong International Airport (HKIA) have launched an airport-to-airport (A2A) corridor for pharma shippers in collaboration with Pharma.Aero.

Pharma.Aero and shippers will now establish key performance indicators for ground handling and air carriage standards based on IATA’s Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification.

Both HKIA and Brussels Airport are CEIV certified and provide shippers with seamless, temperature-controlled storage and transportation including cool dollies for apron transfers.

“We are pleased to collaborate with Brussels Airport to establish this A2A pharma corridor,” declared Alaina Shum, Hong Kong Airport Authority general manager Aviation Logistics. “To ensure airport-wide seamless temperature-controlled handling, we are taking delivery of 19 additional cool dollies for common-use by the airlines, meaning that all airlines will always have the option to deploy cool dollies for their temperature-sensitive shipments. We are also building apron shelters to protect the pharmaceutical shipments from direct weather elements.”

BRU pharma dolliesAccording to Steven Polmans, head of Cargo and Logistics for Brussels Airport, the cooperation with HKIA is a first step in creating specialised, dedicated pharma corridors. “Our pharma volumes between Brussels and Hong Kong as well as the rest of Asia and Australia are significant, so this improved solution for our customers is being welcomed by the market very much.”

Pharma.Aero secretary general Frank Van Gelder said pharma companies MSD and Pfizer had provided “great support” for the new corridor project: “Their participation will help to validate the services and key performance indices of the A2A pharma corridor, making sure it provides all pharmaceuticals shippers the genuine value and peace of mind.”

Commenting on the growth in Brussels pharma traffic Polmans added: “Love it when a dedicated strategy and hard work and passion pays off. In 2018 our export pharma volumes saw a spectacular increase of 32 percent. For the third year in a row a double digit growth that does not start with a 1... Proud of all partners @BRUcargo working day in day out to make this happen.”

Brussels Airport reports Belgium exported €40.3 billion of proprietary medicines in 2017, some 10.6 percent of the country's total exports. “Nearly half (48.9 percent) of these exports are intended for countries outside the European Union,” said Catherine Rutten, the CEO of pharma.be, the representing 130 Belgian pharmaceutical companies. “In part, it is thanks to the investments of the logistical partners, such as Brussels Airport Company, that Belgium is a preferred country for pharma exports to overseas countries. Doing so also sees our country play its part in the pursuit of the global health objectives,” she added.

freightHub2020 BannerSMALL




- powered by Quickchilli.com -